SCHEMBL577645

SCHEMBL577645

CC(C)c1csc(-c2[c]nc3ccccc3c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR4 P51679 1/20 0.38
TYK2 P29597 1/20 0.35
GCK P35557 1/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
GLA P06280 1/20 0.32
HPGD P15428 1/20 0.32
ACHE P22303 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
GRM1 Q13255 1/20 0.32
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
CSNK2A1 P68400 1/20 0.31
CSNK2A3 Q8NEV1 1/20 0.31
HAO1 Q9UJM8 2/20 0.31
TLR8 Q9NR97 1/20 0.31
RAB9A P51151 1/20 0.30
PAX8 Q06710 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3724060 0.76 IDH1 (0.31) MAPTALDH1A1GLAHPGDACHE
SCHEMBL577313 0.74 CCR4 (0.39) CCR4TYK2ALDH1A1HPGDCYP1A2
SCHEMBL577312 0.74 CCR4 (0.39) CCR4TYK2ALDH1A1HPGDCYP1A2
SCHEMBL576843 0.73 CCR4 (0.38) CCR4TYK2CSNK2A2CSNK2BCSNK2A1
SCHEMBL576844 0.73 CCR4 (0.38) CCR4TYK2CSNK2A2CSNK2BCSNK2A1
SCHEMBL3417300 0.72 RAB9A (0.50) MAPTALDH1A1GLAHPGDACHE
SCHEMBL5279906 0.72 MAPT (0.35) MAPTALDH1A1GLAHPGDACHE
SCHEMBL577568 0.71 CCR4 (0.36) CCR4TYK2CSNK2A2CSNK2BCSNK2A1
SCHEMBL577569 0.71 POLB (0.41) CCR4ALDH1A1CSNK2A2CSNK2BCSNK2A1
SCHEMBL2893870 0.70 RAB9A (0.46) MAPTALDH1A1GLAHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP disclosed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 EP disclosed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO disclosed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed